The humoral pattern recognition molecule PTX3 is a key component of innate immunity against urinary tract infection.
Jaillon S
Immunity. 40(4):621-32. doi: 10.1016/j.immuni.2014.02.015
PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer.
Bonavita E
Cell. 160(4):700-714. doi: 10.1016/j.cell.2015.01.004
Phagocytes as Corrupted Policemen in Cancer-Related Inflammation.
Bonavita E
Adv Cancer Res. 2015 Jun 16;128:141-71. doi: 10.1016/bs.acr.2015.04.013
IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity.
Molgora M
Nature. 2017 Oct 25;551(7678):110-114. doi: 10.1038/nature24293
Resolving the dark side of therapy-driven cancer cell death.
Bonavita E, Pelly VS, Zelenay S
J Exp Med. 2017 Dec 20;215(1):9-11. doi: 10.1084/jem.20172044
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control.
Böttcher JP
Cell. 2018 Feb 8;172(5):1022-1037.e14. doi: 10.1016/j.cell.2018.01.004
Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors.
Ponzetta A
Cell. 2019 Jun 27;178(2):346-360.e24. doi: 10.1016/j.cell.2019.05.047
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade.
Bonavita E
Immunity. 2020 Nov 20;53(6):1215-1229.e8. doi: 10.1016/j.immuni.2020.10.020
Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy.
Pelly VS
Cancer Discov. 2021 May 24;11(10):2602-2619. doi: 10.1158/2159-8290.CD-20-1815
Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations.
Bell CR
Nat Commun. 2022 Apr 19;13(1):2063. doi: 10.1038/s41467-022-29606-9